DE60003196D1 - Ciprofloxacin enthaltende pharmazeutische zusammensetzung und verfahren zu deren herstellung - Google Patents

Ciprofloxacin enthaltende pharmazeutische zusammensetzung und verfahren zu deren herstellung

Info

Publication number
DE60003196D1
DE60003196D1 DE60003196T DE60003196T DE60003196D1 DE 60003196 D1 DE60003196 D1 DE 60003196D1 DE 60003196 T DE60003196 T DE 60003196T DE 60003196 T DE60003196 T DE 60003196T DE 60003196 D1 DE60003196 D1 DE 60003196D1
Authority
DE
Germany
Prior art keywords
weight
ciprofloxacin
composition containing
pharmaceutical composition
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60003196T
Other languages
English (en)
Other versions
DE60003196T2 (de
Inventor
Pal Fekete
Gyoergyne Fellner
Laszlone Gora
Istvanne Jambor
Szilvia Feikus
Zoltanne Palfi
Zsolt Zsigmond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of DE60003196D1 publication Critical patent/DE60003196D1/de
Application granted granted Critical
Publication of DE60003196T2 publication Critical patent/DE60003196T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60003196T 1999-08-11 2000-08-11 Ciprofloxacin enthaltende pharmazeutische zusammensetzung und verfahren zu deren herstellung Expired - Fee Related DE60003196T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9902725 1999-08-11
HU9902725A HU227070B1 (en) 1999-08-11 1999-08-11 Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
PCT/HU2000/000090 WO2001012162A1 (en) 1999-08-11 2000-08-11 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof

Publications (2)

Publication Number Publication Date
DE60003196D1 true DE60003196D1 (de) 2003-07-10
DE60003196T2 DE60003196T2 (de) 2004-04-29

Family

ID=89999030

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60003196T Expired - Fee Related DE60003196T2 (de) 1999-08-11 2000-08-11 Ciprofloxacin enthaltende pharmazeutische zusammensetzung und verfahren zu deren herstellung

Country Status (13)

Country Link
EP (1) EP1207857B1 (de)
AT (1) ATE241967T1 (de)
AU (1) AU6716100A (de)
BG (1) BG106404A (de)
CZ (1) CZ2002505A3 (de)
DE (1) DE60003196T2 (de)
HK (1) HK1046234B (de)
HU (1) HU227070B1 (de)
PL (1) PL352331A1 (de)
RU (1) RU2251420C2 (de)
SK (1) SK285236B6 (de)
UA (1) UA72270C2 (de)
WO (1) WO2001012162A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
WO2005021000A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Solid oral dosage forms of gatifloxacin
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1880722B1 (de) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmazeutische Zubereitungen von Ciprofloxacin
CN107669645A (zh) * 2017-10-31 2018-02-09 瑞阳制药有限公司 盐酸环丙沙星片的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
EP0918513B1 (de) * 1996-08-15 2000-12-06 Losan Pharma GmbH Gut schluckbare orale arzneiform

Also Published As

Publication number Publication date
CZ2002505A3 (cs) 2002-06-12
PL352331A1 (en) 2003-08-11
HK1046234A1 (en) 2003-01-03
WO2001012162A1 (en) 2001-02-22
UA72270C2 (en) 2005-02-15
SK285236B6 (sk) 2006-09-07
RU2251420C2 (ru) 2005-05-10
HU9902725D0 (en) 1999-10-28
SK2132002A3 (en) 2002-08-06
EP1207857A1 (de) 2002-05-29
BG106404A (en) 2002-09-30
DE60003196T2 (de) 2004-04-29
EP1207857B1 (de) 2003-06-04
RU2002106727A (ru) 2004-01-10
HU227070B1 (en) 2010-06-28
ATE241967T1 (de) 2003-06-15
HK1046234B (zh) 2004-03-19
AU6716100A (en) 2001-03-13
HUP9902725A2 (hu) 2001-12-28

Similar Documents

Publication Publication Date Title
PE20010982A1 (es) Composicion estable para dosis oral de liberacion extendida
WO2007048219A3 (en) Sustained drug release composition
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
ES2181055T3 (es) Formulaciones galenicas que contienen antagonistas de opiaceos.
ME00298B (me) Farmaceutski preparat
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
ATE300941T1 (de) Pharmazeutische formulierung enthaltend tolterodin sowie ihre verwendung
PL410219A1 (pl) Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca
UY24288A1 (es) Procedimiento para la preparación de una composición de liberación retardada de paroxetina
EE200100458A (et) Ravimaine kombinatsioonis prootonpumba inhibiitori või H2 retseptori antagonistiga ning neid sisaldav farmatseutiline kompositsioon kasutamiseks mao-soolkonna häirete ravis
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
WO2007021968A3 (en) Sustained release antihistamine and decongestant composition
ATA90122000A (de) Stabilisierte orale pharmazeutische zusammensetzung, die jodid und jodat enthält und verfahren zu deren herstellung
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
PE20080400A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
DE50212267D1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
DE69632194D1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
ATE241967T1 (de) Ciprofloxacin enthaltende pharmazeutische zusammensetzung und verfahren zu deren herstellung
EA200200914A1 (ru) Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
ATE252544T1 (de) Hochreine (1r, 2s, 4r)-(-)-2-((2'-(n,n- dimethylamino)-ethoxy))-2-(phenyl)-1,7,7-tri- (methyl)-bicyclo(2.2.1)heptan und ihre pharmazeutisch akzeptierbaren säure-additions- salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament.
YU87501A (sh) Farmaceutski kompleksi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee